The diabetes management experiences questionnaire: Psychometric validation among adults with type 1 diabetes

Christel Hendrieckx, Hanafi M. Husin, Sienna Russell-Green, Jennifer A. Halliday, Benjamin Lam, Steven Trawley, Sybil A. McAuley, Leon A. Bach, Morton G. Burt, Neale D. Cohen, Peter G. Colman, D. Jane Holmes-Walker, Alicia J. Jenkins, Melissa H. Lee, Roland W. McCallum, Steve N. Stranks, Vijaya Sundararajan, Tim W. Jones, David N. O'Neal, Jane Speight

Research output: Contribution to journalArticlepeer-review


AIMS: To examine the psychometric properties of the Diabetes Management Experiences Questionnaire (DME-Q). Adapted from the validated Glucose Monitoring Experiences Questionnaire, the DME-Q captures satisfaction with diabetes management irrespective of treatment modalities.

METHODS: The DME-Q was completed by adults with type 1 diabetes as part of a randomized controlled trial comparing hybrid closed loop (HCL) to standard therapy. Most psychometric properties were examined with pre-randomization data (n = 149); responsiveness was examined using baseline and 26-week follow-up data (n = 120).

RESULTS: Pre-randomization, participants' mean age was 44 ± 12 years, 52% were women. HbA1c was 61 ± 11 mmol/mol (7.8 ± 1.0%), diabetes duration was 24 ± 12 years and 47% used an insulin pump prior to the trial. A forced three-factor analysis revealed three expected domains, that is, 'Convenience', 'Effectiveness' and 'Intrusiveness', and a forced one-factor solution was also satisfactory. Internal consistency reliability was strong for the three subscales ( α $$ \alpha $$ range = 0.74-0.84) and 'Total satisfaction' ( α $$ \Big(\alpha $$  = 0.85). Convergent validity was demonstrated with moderate correlations between DME-Q 'Total satisfaction' and diabetes distress (PAID: rs  = -0.57) and treatment satisfaction (DTSQ; rs  = 0.58). Divergent validity was demonstrated with a weak correlation with prospective/retrospective memory (PRMQ: rs  = -0.16 and - 0.13 respectively). Responsiveness was demonstrated, as participants randomized to HCL had higher 'Effectiveness' and 'Total satisfaction' scores than those randomized to standard therapy.

CONCLUSIONS: The 22-item DME-Q is a brief, acceptable, reliable measure with satisfactory structural and construct validity, which is responsive to intervention. The DME-Q is likely to be useful for evaluation of new pharmaceutical agents and technologies in research and clinical settings.

Original languageEnglish
Article numbere15195
JournalDiabetic medicine : a journal of the British Diabetic Association
Issue number3
Early online date10 Aug 2023
Publication statusPublished - Mar 2024


Dive into the research topics of 'The diabetes management experiences questionnaire: Psychometric validation among adults with type 1 diabetes'. Together they form a unique fingerprint.

Cite this